Biktarvy, formally known as bictegravir sulfate, includes a effective single-tablet therapy for controlling HIV infection. This medication integrates three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking the HIV's ability to replicate within the body, considerably decreasing the viral burden.